Executive Service AgreementService Agreement • August 5th, 2008 • Protherics PLC • Pharmaceutical preparations
FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • August 5th, 2008 • Protherics PLC • Pharmaceutical preparations
This first amendment (the “Amendment”) to License Agreement is effective as of April 15, 2008 (the “Amendment Effective Date”), by on the one hand Protherics Medicines Development Limited (“Protherics”), and on the other hand, Glenveigh Pharmaceuticals, LLC, Glenveigh Research, LLC, C. David Adair, M.D., CDA Royalty Investors, LLC, and CDA Licensing Administrators, LLC (collectively, each such entity and individual referred to individually as a “Glenveigh Holder” and such entities and Dr. Adair, referred to collectively as “Glenveigh”). Protherics and Glenveigh may be referred to herein individually as a “Party” and collectively as the “Parties.”
PROTHERICS MOLECULAR DESIGN LIMITED and IDIS LIMITED SUPPLY AND DISTRIBUTION AGREEMENTSupply and Distribution Agreement • August 5th, 2008 • Protherics PLC • Pharmaceutical preparations • England and Wales
